EOLSEvolus Inc
EOLS
Evolus Inc3,868
Mkt Cap
$344.82MVolume
830,961.0052W High
$12.2852W Low
$3.86PE Ratio
-6.60EOLS Fundamentals
Price
$5.30Prev Close
$5.31Open
$5.2950D MA
$4.62Beta
1.13Avg. Volume
1.65MEPS (Annual)
-$0.801P/B
-14.91Rev/Employee
$889,748.50$529.89
Evolus, Inc. (NASDAQ:EOLS) Given Consensus Rating of "Moderate Buy" by Analysts
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommenda...
MarketBeat·6d ago
Short Interest in Evolus, Inc. (NASDAQ:EOLS) Drops By 14.4%
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) was the target of a large decline in short interest in March. As of March 31st, there was short interest totaling 6,517,006 shares, a decline of 14.4...
MarketBeat·9d ago
Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference
Evolus (NASDAQ:EOLS) executives told investors at Needham & Company's 25th Annual Healthcare Conference that the company is pursuing double-digit growth and a transition to full-year profitability as...
MarketBeat·11d ago
Evolus to Report First Quarter Financial Results on May 4, 2026
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its first quarter 2026 financial...
Business Wire·13d ago
FY2026 Earnings Forecast for Evolus Issued By HC Wainwright
Evolus, Inc. (NASDAQ:EOLS - Free Report) - Analysts at HC Wainwright reduced their FY2026 EPS estimates for shares of Evolus in a research note issued to investors on Monday, March 30th. HC...
MarketBeat·26d ago
Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a...
Business Wire·27d ago
Evolus, Inc. (NASDAQ:EOLS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Evolus, Inc. (NASDAQ:EOLS - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six research firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four hav...
MarketBeat·1mo ago
Evolus (NASDAQ:EOLS) Insider Sells 3,119 Shares
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) insider Rui Avelar sold 3,119 shares of the business's stock in a transaction dated Friday, March 20th. The stock was sold at an average price of $4.75, for a total transaction of $14,815.25. Following the transaction, the insider owned 427,423 shares in...
MarketBeat·1mo ago
Evolus (NASDAQ:EOLS) Insider David Moatazedi Sells 13,669 Shares
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) insider David Moatazedi sold 13,669 shares of the business's stock in a transaction on Friday, March 20th. The stock was sold at an average price of $4.75, for a total transaction of $64,927.75. Following the transaction, the insider directly owned...
MarketBeat·1mo ago
Evolus (NASDAQ:EOLS) Insider Rui Avelar Sells 3,119 Shares
Evolus, Inc. (NASDAQ:EOLS - Get Free Report) insider Rui Avelar sold 3,119 shares of Evolus stock in a transaction that occurred on Friday, March 20th. The stock was sold at an average price of $4.75, for a total transaction of $14,815.25. Following the sale, the insider owned 427,423 shares of the...
MarketBeat·1mo ago
<
1
2
...
>